Dr. Atul Kumar
Claim this profileUniversity of New Mexico Cancer Center
Area of expertise
Lung Cancer
Atul Kumar has run 18 trials for Lung Cancer. Some of their research focus areas include:
Non-Small Cell Lung Cancer
Atul Kumar has run 15 trials for Non-Small Cell Lung Cancer. Some of their research focus areas include:
Affiliated Hospitals
University Of New Mexico Cancer Center
Presbyterian Kaseman Hospital
Clinical Trials Atul Kumar is currently running
Osimertinib + Bevacizumab
for Lung Cancer
This phase III trial compares the effect of bevacizumab and osimertinib combination vs. osimertinib alone for the treatment of non-small cell lung cancer that has spread outside of the lungs (stage IIIB-IV) and has a change (mutation) in a gene called EGFR. The EGFR protein is involved in cell signaling pathways that control cell division and survival. Sometimes, mutations in the EGFR gene cause EGFR proteins to be made in higher than normal amounts on some types of cancer cells. This causes cancer cells to divide more rapidly. Osimertinib may stop the growth of tumor cells by blocking EGFR that is needed for cell growth in this type of cancer. Bevacizumab is in a class of medications called antiangiogenic agents. It works by stopping the formation of blood vessels that bring oxygen and nutrients to tumor. This may slow the growth and spread of tumor. Giving osimertinib with bevacizumab may control cancer for longer and help patients live longer as compared to osimertinib alone.
Recruiting
2 awards
Phase 3
31 criteria
LY3537982 + Immunotherapy/Chemotherapy
for Non-Small Cell Lung Cancer
This trial is testing a new drug, LY3537982, combined with standard treatments for patients with advanced lung cancer that have a specific genetic mutation. The goal is to see if this combination works better than the usual treatments alone.
Recruiting
1 award
Phase 3
14 criteria
More about Atul Kumar
Clinical Trial Related
5 years of experience running clinical trials · Led 22 trials as a Principal Investigator · 6 Active Clinical Trials
Treatments Atul Kumar has experience with
- Pembrolizumab
- Carboplatin
- Atezolizumab
- Pemetrexed
- Talazoparib
- Selpercatinib
Breakdown of trials Atul Kumar has run
Lung Cancer
Non-Small Cell Lung Cancer
Lung Carcinoma
Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Atul Kumar specialize in?
Atul Kumar focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is Atul Kumar currently recruiting for clinical trials?
Yes, Atul Kumar is currently recruiting for 6 clinical trials in Albuquerque New Mexico. If you're interested in participating, you should apply.
Are there any treatments that Atul Kumar has studied deeply?
Yes, Atul Kumar has studied treatments such as Pembrolizumab, Carboplatin, Atezolizumab.
What is the best way to schedule an appointment with Atul Kumar?
Apply for one of the trials that Atul Kumar is conducting.
What is the office address of Atul Kumar?
The office of Atul Kumar is located at: University of New Mexico Cancer Center, Albuquerque, New Mexico 87106 United States. This is the address for their practice at the University of New Mexico Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.